Mark B Abelson Selected Research

Olopatadine Hydrochloride (Patanol)

11/2008	A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
4/2008	Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
12/2007	Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.
7/2007	Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
10/2005	Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.
5/2005	Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
12/2004	Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
9/2004	A review of olopatadine for the treatment of ocular allergy.
8/2004	Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.
1/2004	Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark B Abelson Research Topics

Disease

28	Pruritus (Itching) 01/2019 - 03/2002
25	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2017 - 03/2002
13	Hypersensitivity (Allergy) 01/2019 - 03/2002
11	Hyperemia 08/2011 - 03/2002
4	Dry Eye Syndromes (Dry Eye Syndrome) 11/2017 - 07/2005
4	Allergic Rhinitis 01/2017 - 08/2003
3	Glaucoma 01/2005 - 01/2003
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2017 - 03/2003
2	Rhinorrhea 07/2010 - 05/2005
2	Ocular Hypertension (Glaucoma, Suspect) 11/2003 - 01/2003
1	Sleepiness 01/2018
1	Fatigue 01/2018
1	Asthma (Bronchial Asthma) 04/2017
1	Spasm (Spasms) 02/2009
1	Seizures (Absence Seizure) 02/2009
1	Bacterial Conjunctivitis 06/2008
1	Sneezing 05/2005
1	Cataract (Cataracts) 01/2005
1	Keratitis 11/2004
1	Conjunctivitis 08/2003
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2003

Drug/Important Bio-Agent (IBA)

26	AllergensIBA 01/2019 - 03/2002
18	Ophthalmic Solutions (Eye Drops)IBA 08/2011 - 03/2002
15	Olopatadine Hydrochloride (Patanol)FDA Link 11/2008 - 07/2002
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2004
4	bepotastine besilate FDA Link 08/2011 - 09/2009
4	Histamine Antagonists (Antihistamines)IBA 06/2011 - 07/2008
4	Mast Cell StabilizersIBA 11/2008 - 07/2002
4	Ketotifen (Ketotifene)FDA Link 12/2004 - 07/2002
3	AntigensIBA 01/2004 - 12/2003
2	Nasal SpraysIBA 11/2008 - 08/2003
2	SolutionsIBA 11/2008 - 01/2004
2	levocabastine (Bilina)FDA Link 12/2004 - 01/2004
2	Loratadine (Alavert)FDA Link 11/2004 - 03/2002
2	epinastine FDA Link 01/2004 - 01/2004
2	fexofenadine (Allegra)FDA LinkGeneric 08/2003 - 07/2002
2	Lubricant Eye Drops (Artificial Tears)IBA 07/2003 - 03/2003
1	iodixanol (Visipaque)FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Menthol FDA Link 11/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	ragweed pollenIBA 01/2016
1	Anesthetics (Anesthetic Agents)IBA 06/2010
1	fluticasone furoate FDA Link 11/2008
1	SteroidsIBA 11/2008
1	ketotifen fumarate ophthalmic solution (Zaditor)FDA Link 07/2008
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2005
1	Cetirizine (Zyrtec)FDA LinkGeneric 11/2004
1	Histamine Receptors (Histamine Receptor)IBA 09/2004
1	Aligeron (AS 2)IBA 08/2004
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 11/2003
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 08/2003
1	Pheniramine (Pheniramine Maleate)FDA Link 07/2003
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 07/2003
1	Antazoline (Antazoline Phosphate)FDA Link 07/2003
1	Bimatoprost (Lumigan)FDA Link 01/2003
1	PotassiumIBA 10/2002
1	pemirolast (Alamast)FDA Link 10/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2002
1	Fluticasone (Cutivate)FDA LinkGeneric 07/2002
1	emedastine FDA Link 03/2002

Therapy/Procedure

6	Therapeutics 07/2009 - 03/2002
1	Drug Therapy (Chemotherapy) 06/2015
1	Slit Lamp 06/2010
1	Topical Administration 01/2005
1	Aftercare (After-Treatment) 07/2002